(NICE) Nice - Ratings and Ratios
AI Cloud Platform, Customer Engagement, Financial Crime, Compliance, Digital Evidence
NICE EPS (Earnings per Share)
NICE Revenue
Description: NICE Nice November 03, 2025
NICE Ltd. (NASDAQ:NICE) delivers AI-driven cloud platforms that span three core verticals: customer experience (CXone Mpower), financial-crime compliance (Xceed and data-intelligence suites), and digital evidence management for the criminal-justice system (Evidencentral). The firm’s X-Sight platform targets high-end enterprise customers with a flexible AI-cloud stack, while its subscription-based model now generates roughly 80 % of total revenue, underscoring the shift toward recurring SaaS income.
Key performance indicators from FY 2023 show total revenue of about $1.5 billion, a year-over-year increase of 13 %, and a 28 % YoY growth in cloud-subscription ARR, reflecting strong demand for AI-enabled contact-center solutions. The global contact-center software market is projected to expand at a CAGR of ~23 % through 2029, driven by digital-first consumer expectations and the need for scalable automation.
Regulatory pressure on anti-money-laundering (AML) and fraud detection continues to accelerate adoption of NICE’s compliance suite, especially among mid-size financial institutions that are increasingly required to meet stricter reporting standards. Assuming the firm can sustain its R&D spend (≈15 % of revenue) to stay ahead of rapid AI advances, the upside potential remains tied to the broader AI-software adoption cycle.
For a deeper, data-driven assessment of NICE’s valuation and risk profile, you might explore the analytics platform ValueRay, which aggregates real-time financial metrics and peer benchmarks.
NICE Stock Overview
| Market Cap in USD | 8,229m |
| Sub-Industry | Application Software |
| IPO / Inception | 1996-01-24 |
NICE Stock Ratings
| Growth Rating | -73.0% |
| Fundamental | 86.2% |
| Dividend Rating | 6.67% |
| Return 12m vs S&P 500 | -41.3% |
| Analyst Rating | 4.33 of 5 |
NICE Dividends
Currently no dividends paidNICE Growth Ratios
| Growth Correlation 3m | -51.9% |
| Growth Correlation 12m | -74.5% |
| Growth Correlation 5y | -82.2% |
| CAGR 5y | -14.72% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.28 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.61 |
| Sharpe Ratio 12m | 0.02 |
| Alpha | -36.24 |
| Beta | 0.320 |
| Volatility | 34.73% |
| Current Volume | 620.1k |
| Average Volume 20d | 476.8k |
| Stop Loss | 120 (-3.2%) |
| Signal | -0.95 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (537.1m TTM) > 0 and > 6% of Revenue (6% = 170.3m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 0.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 40.62% (prev 53.46%; Δ -12.84pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 754.9m > Net Income 537.1m (YES >=105%, WARN >=100%) |
| Net Debt (3.98m) to EBITDA (791.6m) ratio: 0.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (63.2m) change vs 12m ago -4.02% (target <= -2.0% for YES) |
| Gross Margin 67.03% (prev 67.06%; Δ -0.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 54.79% (prev 50.44%; Δ 4.35pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 98.48 (EBITDA TTM 791.6m / Interest Expense TTM 6.11m) >= 6 (WARN >= 3) |
Altman Z'' 5.63
| (A) 0.22 = (Total Current Assets 2.54b - Total Current Liabilities 1.38b) / Total Assets 5.31b |
| (B) 0.51 = Retained Earnings (Balance) 2.70b / Total Assets 5.31b |
| (C) 0.12 = EBIT TTM 601.8m / Avg Total Assets 5.18b |
| (D) 1.68 = Book Value of Equity 2.65b / Total Liabilities 1.58b |
| Total Rating: 5.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.19
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 9.25% = 4.62 |
| 3. FCF Margin 23.26% = 5.81 |
| 4. Debt/Equity 0.14 = 2.49 |
| 5. Debt/Ebitda 0.01 = 2.50 |
| 6. ROIC - WACC (= 9.03)% = 11.29 |
| 7. RoE 14.93% = 1.24 |
| 8. Rev. Trend 98.23% = 7.37 |
| 9. EPS Trend -22.78% = -1.14 |
What is the price of NICE shares?
Over the past week, the price has changed by -9.27%, over one month by -8.26%, over three months by -16.58% and over the past year by -33.09%.
Is Nice a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NICE is around 96.44 USD . This means that NICE is currently overvalued and has a potential downside of -22.22%.
Is NICE a buy, sell or hold?
- Strong Buy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NICE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 197.1 | 58.9% |
| Analysts Target Price | 197.1 | 58.9% |
| ValueRay Target Price | 105.9 | -14.6% |
NICE Fundamental Data Overview October 27, 2025
P/E Trailing = 15.8065
P/E Forward = 10.2564
P/S = 2.8992
P/B = 2.2871
P/EG = 0.855
Beta = 0.32
Revenue TTM = 2.84b USD
EBIT TTM = 601.8m USD
EBITDA TTM = 791.6m USD
Long Term Debt = 79.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 472.2m USD (from shortTermDebt, last quarter)
Debt = 539.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.98m USD (from netDebt column, last quarter)
Enterprise Value = 7.14b USD (8.23b + Debt 539.0m - CCE 1.63b)
Interest Coverage Ratio = 98.48 (Ebit TTM 601.8m / Interest Expense TTM 6.11m)
FCF Yield = 9.25% (FCF TTM 660.1m / Enterprise Value 7.14b)
FCF Margin = 23.26% (FCF TTM 660.1m / Revenue TTM 2.84b)
Net Margin = 18.92% (Net Income TTM 537.1m / Revenue TTM 2.84b)
Gross Margin = 67.03% ((Revenue TTM 2.84b - Cost of Revenue TTM 935.8m) / Revenue TTM)
Gross Margin QoQ = 66.75% (prev 66.85%)
Tobins Q-Ratio = 1.34 (Enterprise Value 7.14b / Total Assets 5.31b)
Interest Expense / Debt = 1.13% (Interest Expense 6.11m / Debt 539.0m)
Taxrate = -6.84% (negative due to tax credits) (-12.0m / 175.4m)
NOPAT = 643.0m (EBIT 601.8m * (1 - -6.84%)) [negative tax rate / tax credits]
Current Ratio = 1.83 (Total Current Assets 2.54b / Total Current Liabilities 1.38b)
Debt / Equity = 0.14 (Debt 539.0m / totalStockholderEquity, last quarter 3.73b)
Debt / EBITDA = 0.01 (Net Debt 3.98m / EBITDA 791.6m)
Debt / FCF = 0.01 (Net Debt 3.98m / FCF TTM 660.1m)
Total Stockholder Equity = 3.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.12% (Net Income 537.1m / Total Assets 5.31b)
RoE = 14.93% (Net Income TTM 537.1m / Total Stockholder Equity 3.60b)
RoCE = 16.37% (EBIT 601.8m / Capital Employed (Equity 3.60b + L.T.Debt 79.4m))
RoIC = 15.85% (NOPAT 643.0m / Invested Capital 4.06b)
WACC = 6.82% (E(8.23b)/V(8.77b) * Re(7.19%) + D(539.0m)/V(8.77b) * Rd(1.13%) * (1-Tc(-0.07)))
Discount Rate = 7.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.95%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈646.8m ; Y1≈798.0m ; Y5≈1.36b
Fair Price DCF = 375.0 (DCF Value 23.16b / Shares Outstanding 61.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -22.78 | EPS CAGR: -55.48% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.23 | Revenue CAGR: 10.32% | SUE: 4.0 | # QB: 1
Additional Sources for NICE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle